Reliance on a single AD mouse model
The study primarily relies on a single transgenic mouse model (APP/PS1) for in vivo experiments. While this model is commonly used in AD research, it doesn't fully capture the complexity of the human disease. Findings might not translate to other models or humans.
Correlation does not equal causation
Although the study shows a correlation between mitochondrial calcium overload and neuronal death, it doesn't definitively establish causality. Other factors related to Aβ pathology might contribute to neuronal death independently of mitochondrial calcium.
Technical limitations of in vivo imaging
The in vivo imaging techniques used, while sophisticated, might still be subject to limitations in resolution and signal-to-noise ratio. This might affect the accuracy of mitochondrial calcium measurements, particularly in fine neuronal processes.
Limited exploration of gene expression changes
The study observes changes in mitochondrial gene expression in human AD brains, but the functional consequences of these changes are not fully explored. Further investigation is needed to determine how these changes contribute to mitochondrial dysfunction and AD progression.
Acute Aβo application and short experimental durations in vivo do not necessarily reflect the long term effects and accumulation of mitochondrial calcium
The authors acknowledge this limitation.
Mitochondrial Ca2+ overload only affects a small fraction of mitochondria
Though small, this raises questions of how to effectively and specifically target this population without disrupting the health of the vast majority of normal mitochondria.
Limited analysis of mitochondrial dynamics
The authors briefly mention mitochondrial morphology changes, but lack a detailed explanation about the effects of Aβ and Ca2+ on mitochondrial dynamics, such as fusion, fission, and mitophagy.